🇺🇸 FDA

Drug profile · INN

ergoloid mesylates

GERIMAL

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

ergoloid mesylates (GERIMAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN ergoloid mesylates
Brand GERIMAL
Route ORAL
Formulation CAPSULE

Frequently asked questions

What is ergoloid mesylates?

ergoloid mesylates (GERIMAL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for ergoloid mesylates?

GERIMAL is a marketed brand name for ergoloid mesylates. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ergoloid mesylates?

ergoloid mesylates has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.